A Randomized, Double Blind, Placebo-controlled Proof-of-concept Study of FP187 in Patients With Mild to Moderate Psoriatic Arthritis
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2017
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Psoriatic arthritis
- Focus Proof of concept; Therapeutic Use
- 22 Oct 2016 Status changed from discontinued to withdrawn prior to enrolment.
- 08 Apr 2016 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
- 23 Jun 2015 New trial record